Member Info for raharh

As only 2 months into trading and made some real mistakes and been spiked a few times (dont talk to me about ODX!) after the last presentation and this one tonight - to be honest I dont care about tomorrows share price. The value here is in the next few months as news flow of antobody testing, challenge studies and immutex (months not weeks or years).

CF I think was being subtle putting it in the shop window to a prospective buyer.

But as it would be rude not to , for fun , 16.25p

RK always balanced and informative - thank you for continual posts.

For me the Cytvia LFD test is the one. Football returning, airports re-opening etc... this is the test that lets you screen people on entry to airports or footballers twice weekly without going to a GP etc... Demand will be repeated and then there will be the medusa19 angle for individuals that need to know this week and again in two weeks etc... to protect themselves and loved ones. Therefore with the minimal infection rate at the moment around the world this will be by far be one to transform the company I would guess.

If Adeptrix comes back first on RNS (as indicated) it should prove the Cytvia concept and therefore it will be a manufacturing issue surely.

MosaiQ to test twice each week ? Contracts to sign ?

You will see from any of my previous posts I was pretty bruised yesterday, didnt think the CEO interview was great, but reviewed that under the lens of a drop when the RNS came out - not very objective. I am vastly inexperienced to most of the investors on this board. Yes, I panicked and sold at 72p in the drop, it was the lethargy of seeing other covid stocks rise and this slowly slide down each day. Made a small profit (only had a £1000 in at 58p) but smarted about it all night as could not work out how i felt. I invested here first before any other share as the attractiveness was the manufacturing capability and RTC with Mologic being a cherry on the top.

After a good nights sleep I had a word with myself and decided that I should just remember why I invested in the first place and to stop being jittery and the RNS actually confirmed things are coming.

So I woke up, sold up some of my Avacta and put the money i got out and a bit more back in so now have more shares than yesterday and got in at 71p this morning .... there are a lot of new investors and I am one - ironically i now have more shares than yesterday (and less in Avacta).

My morale is to stop refreshing google on my shares every five minutes and let the companies do there work. I spent a month looking at omega, avacta and open orphan and i spent 5 minutes panicking and selling up, i need to get a grip of myself. i know a month is not a long time but i did use the boards and probably didnt go as deep as most, but i decided to enter the fray. I have read as many reasons to invest in shares on these boards as I have to sell them - they are a nightmare at times and you can convince yourself either way.

Once this test is available it is the public, international sales and supply through the government to hospitals and GPs etc... so there can be a quick test to check people for antibodies in surgeries etc.... I can see it being huge and the interview all but confirmed they are there. Yes an RNS will confirm it but I saw the reaction yesterday when people saw the interview and inferred it was as good as the RNS. Imagine when it does drop.

I am getting back in my box and holding now, the lockdown has created an opportunity to look at shares and dealing but it isnt for the faint hearted!

My only advice is stay calm ... these do seem to be roller coasters.

Shame they cannot RNS that reply ......
Hey ho - it will get there.

Eskers - I may be wrong - you may be right - linked to the article it certainly looks like the same.

Last quote in the article: "We have 12 of these instruments available at the moment and we’re in ­discussions with labs in France, Spain and in the US. ****We’ve already sold to a private lab in London.***"

However I thought CF had UK exclusivity - wouldn't they just point the government to Open Orphan?

Is this the right company (I may be confused) as the reference is to Quotient in Mid Lothian. There is a Quotient Sciences in Mid Lothian which has offices in the US. But the machine is from QuotientMD as per the tweet they put out May 20 saying the machine was being shipped to Open Orphan.

Don't know if the politician is mixed up as they dont seem to have an antibody test or whether its me.

Brain drain ..... hopefully CF will cheer me up tomorrow evening!

Guys. I hope the boards are polite and informative before I ask .....
I have looked at HEMO before and yes I have decided to cash out of ODX (with a profit) more down to the confidence in the leadership team there now. The board is large so could someone just point me to a link or provide information relating to the 4th June event. It seems an excellent entry point at the moment especially considering there was an over subscribed placement at 7p I believe (please let me know if I have misinterpreted this).

This must nail no RNS tomorrow on Design Freeze otherwise why issue the speeding ticket. I think he was ambiguous in the interview and this led to excitement and has driven the share price. If they were at freeze he would have kept quiet and issued the RNS OOH. If there is an RNS then it is really poor management, if there isnt it is really poor management ........

Great potential but poor investor relations.

Punit - I am with you! I got in at 58.5 and it has been a few weeks of waiting but worth it. Hard to hold your nerve when you see others taking off but I always thought at home antibody tests would, if nothing else psychologically, get the economy going - people need comfort to act normally. An antigen test is important (I am in Avacta) but that doesnt help me know if I can get infected, it tells me if I have it. This tells me I am probably immune (subject to medical opinion) and so more valuable in seeing my loved ones and going back to normal(ish)

Roll on June and RNS on design freeze and sales.

muir - i agree - i wasnt actually saying anyone should move (i am not). No need to get worried about people offloading to chase others - this is a solid investment and a really strong CEO IMO.

Looking at volumes a lot of money is probably moving to ODX post CEO Sky interview, and why not if that's what people want to do. I would imagine a lot of people are in both for their relative risk profile (as am I). My investment is modest reading these BBs but as far as Avacta is concerned we have a long way to go.

I would expect the Adeptrix results first as the CEO mentioned, however, if that works then this is total confidence in the Cytvia test (it's just the manufacturing isnt it - the Affimer will be proven by Adeptrix). Finally lets not forget about the Pharma partner they are looking at for treatment.

RNS this week on Adeptrix would consolidate and move the SP up to confirm the £2+ before the bigger mover with Cytvia

And this is just the Covid space.

Lots of good shares, spread your risk and back your horses but i see no reason to sell yet, we all have our targets! DYOR BLAH BLAH BLAH

I was new to trading in March and a colleague said they used EQI.

Simple and easy to use and never down so thats what I use.

I just think we need to get by 29th May. Even if RNS drops this week I am personally looking forward to next week onwards when placing is out of the way.

CF doing an interview tomorrow is good, maybe pre-empting an RNS. Not worrying about ups and downs daily, yesterday was unexpected with the placing coming so averaging out the week we seem to be in a good place.

Just awaiting the recruitment for challenge studies (and contracts) and to hear the Quotient machine is fully booked.

Matt Han**** tonight so probably worth a watch to hopefully say they have taken the Open Orphan capacity! John Newton as well for those in ODX.

Agreed - i was reflecting on the BB being upset at CF dampening the SP a few weeks ago and all became clear when the placing came out. Now it is definitely been let go supported by new IIs. As soon as we get some contract details for the Quotient machines (another one on order potentially) and the challenge studies (they are advertising now for participants) then it will really move. CF is a shrewd business man who also has the PIs in mind I think so I think I will not be letting my shares go anytime soon.

Would be useful if SeethreePO was about to share the L2 data like last week so we can see the drivers and parameters as we enjoy this ride.

ODX are working on a point of contact (POC) antibody test to see if you have had the virus (and thereby may have some immunity)

AVACTA are working on a lab based (BAMS) and POC antigen test to see if you have the virus (and therefore should self isolate etc..) amongst a 100 other things

Sirius
Definately not trading - I am holding and my holding is small (but its all mine!). It was just interesting to see what orders were sat there by MMs . The board is useful for Avacta advancement but also my learning process.

SeethreePO posted some L2 data on Friday which was very useful (and there was a link explaining it to us less experienced!)

Does anyone have that as it seems to be moving again and was interested to watch the SP tied to the data.